GRIA2 and fragile X syndrome: Expression of GluA1 and GluA2 mRNAs is reduced in the prefrontal cortex of the Fmr1 KO mouse when compared to wild-type controls (Achuta et al., 2018), but it is not known whether the changes of AMPAR expression observed in the FXS mouse brain correlate with changes in human brain.